Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors-Reference-Cited by-同舟云学术

Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors

Published:2020-08 Issue:2 Volume:56 Page:106055
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

He Jun,Hu Lijun,Huang Xiaojun,Wang Chenran,Zhang Zhimin,Wang Ying,Zhang Dongmei,Ye Wencai

Funder

Jinan University

Publisher

Elsevier BV

Reference51 articles.

1. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2;Sanche;Emerg Infect Dis,2020

2. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia;Jin;Mil Med Res,2020

3. The reproductive number of COVID-19 is higher compared to SARS coronavirus;Liu;J Travel Med,2020

4. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics

5. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges;Lai;Int J Antimicrob Agents,2020

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a magnetic beads-based ligand fishing method for screening SARS-CoV-2 NSP5 inhibitors from complex herbal mixtures: Rosmarinus officinalis as a case study;Journal of Chromatography A;2025-07

2. Development of Peptidomimetic PROTACs as Potential Degraders of 3-Chymotrypsin-like Protease of SARS-CoV-2;International Journal of Molecular Sciences;2025-04-21

3. In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication;Viruses;2025-03-28

4. Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay;Scientific Reports;2025-02-26

5. Comparison of Clinical Outcomes between COVID-19 and Influenza in Paediatric Patients: Systematic Review and Meta-Analysis Systematic review and meta-analysis of randomized controlled trials comparing the clinical outcomes of SARS-CoV-2 and influenza in pediatric patients;Advances in Clinical and Experimental Medicine;2025-01-03